Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral vascular disease

[1]  V. Fuster,et al.  AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. , 2001, Circulation.

[2]  M. Criqui,et al.  Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care , 2001 .

[3]  S. Kaplan,et al.  Patients' role in the use of radiology testing for common office practice complaints. , 2001, Archives of internal medicine.

[4]  J. Eikelboom,et al.  Low rates of preventive practices in patients with peripheral vascular disease. , 1999, The Canadian journal of cardiology.

[5]  A. Clark,et al.  Cholesterol in peripheral vascular disease--a suitable case for treatment? , 1999, QJM : monthly journal of the Association of Physicians.

[6]  M. Hollon.  Direct-to-consumer marketing of prescription drugs: creating consumer demand. , 1999, JAMA.

[7]  D L Sackett,et al.  Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. , 1996, Circulation.

[8]  K. Uekama,et al.  Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. , 1995, Clinical chemistry.

[9]  A. Drogendijk,et al.  Determinants of first prescription of hormone replacement therapy. A follow-up study among 1689 women aged 45-60 years. , 1994, Maturitas.

[10]  R. Langer,et al.  Mortality over a period of 10 years in patients with peripheral arterial disease. , 1992, The New England journal of medicine.

[11]  C P Bradley,et al.  Decision making and prescribing patterns--a literature review. , 1991, Family practice.

[12]  L. Kuller,et al.  The ratio of ankle and arm arterial pressure as an independent predictor of mortality. , 1991, Atherosclerosis.

[13]  M. Moran,et al.  Coronary heart disease risk assessment. , 1989, American journal of preventive medicine.

[14]  D. Sumner,et al.  Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity: a six-year follow-up study. , 1989, Journal of vascular surgery.

[15]  P. Fu,et al.  Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.

[16]  I. Rosenstock.  Why people use health services. , 1966, The Milbank Memorial Fund quarterly.

[17]  D. Clement.  A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .